This Tencent Music Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. JMP Securities analyst Reni Benjamin initiated coverage on Summit Therapeutics Inc (NASDAQ:SMMT) with a Market Outperform rating and announced a price target of $32.